October 27, 2015
—PGDx, a leader in cancer genomic analysis and testing, has achieved consistent growth since its inception —NEA leads funding round with support from Windham Venture Partners and Nanjing Kaiyuan Growth … Continued
October 09, 2015
Intranasal Glucagon Could be the First Needle-Free Rescue Treatment for Severe Hypoglycemia INDIANAPOLIS, Oct. 9, 2015 /PRNewswire/ — Eli Lilly and Company (NYSE:LLY) and Locemia Solutions today announced Lilly has acquired … Continued
October 07, 2015
St. Helier, Jersey – NovoCure Limited (NASDAQ: NVCR), a commercial stage oncology company pioneering a novel therapy for solid tumors, announced today the closing of its initial public offering of 7,500,000 … Continued
October 06, 2015
Optune is the first FDA-approved therapy in more than a decade to demonstrate statistically significant extension of survival in newly diagnosed glioblastoma patients The EF-14 trial achieved statistically significant extension … Continued
October 05, 2015
The newly designed, second generation Optune system incorporates state of the art digital technology and is more than 50% lighter and 50% smaller than the first generation system St. Helier, … Continued